Seattle’s Aurion Biotech announced Wednesday that it received special designations from the U.S. Food and Drug Administration that should speed up the development of its treatment for a common disease… Read More
Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that affects millions of people. The startup is a spinoff of Seattle eye care company… Read More
